TCIM
NNVC icon

TIAA CREF Investment Management’s NanoViricides NNVC Stock Holding History

TIAA CREF Investment Management’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,065
Closed -$141K – 3125
2015
Q2 		$141K Sell
4,065
-3,048
-43% -$116K ﹤0.01% 3135
2015
Q1 		$320K Hold
7,113
– – ﹤0.01% 3003
2014
Q4 		$387K Sell
7,113
-347
-5% -$23K ﹤0.01% 3018
2014
Q3 		$448K Hold
7,460
– – ﹤0.01% 3000
2014
Q2 		$627K Buy
+7,460
New +$530K ﹤0.01% 2953

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SIP
Stoneridge Investment Partners Radnor, Pennsylvania $138M AUM 7.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

TIAA CREF Investment Management's NNVC Position: Q3 2015 in Review

TIAA CREF Investment Management sold out of NanoViricides (NNVC) in Q3 2015, closing a stake of 4,065 shares — an estimated $141K sold.

TIAA CREF Investment Management first reported a position in NNVC in Q2 2014 and held it in 5 quarters. The position peaked at $627K in Q2 2014. 45 funds tracked by Wall St. Rank hold NNVC as of Q3 2015.

  • TIAA CREF Investment Management reported no remaining NanoViricides position as of Q3 2015 after selling out during the quarter.
  • TIAA CREF Investment Management sold 4,065 NanoViricides shares in Q3 2015, an estimated $141K.
  • TIAA CREF Investment Management first reported a position in NanoViricides in Q2 2014 and held it in 5 quarters.
  • TIAA CREF Investment Management's NanoViricides position peaked at $627K in Q2 2014.
  • 45 funds tracked by Wall St. Rank held NanoViricides as of Q3 2015.

Based on TIAA CREF Investment Management's 13F filing for Q3 2015, filed 13 Nov 2015.